Cargando…

Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts

BACKGROUND: We projected the clinical and economic impact of alternative testing strategies on COVID-19 incidence and mortality in Massachusetts using a microsimulation model. METHODS: We compared five testing strategies: 1) PCR-severe-only: PCR testing only patients with severe/critical symptoms; 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neilan, Anne M., Losina, Elena, Bangs, Audrey C., Flanagan, Clare, Panella, Christopher, Eskibozkurt, G. Ege, Mohareb, Amir, Hyle, Emily P., Scott, Justine A., Weinstein, Milton C., Siedner, Mark J., Reddy, Krishna P., Harling, Guy, Freedberg, Kenneth A., Shebl, Fatma M., Kazemian, Pooyan, Ciaranello, Andrea L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386528/ https://www.ncbi.nlm.nih.gov/pubmed/32743604 http://dx.doi.org/10.1101/2020.07.23.20160820

Ejemplares similares

Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts
por: Neilan, Anne M, et al.
Publicado: (2020)

Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic
por: Baggett, Travis P., et al.
Publicado: (2020)

Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 Pandemic
por: Baggett, Travis P., et al.
Publicado: (2020)

Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study
por: Reddy, Krishna P., et al.
Publicado: (2020)

Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study
por: Reddy, Krishna P, et al.
Publicado: (2021)

Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
por: Reddy, Krishna P., et al.
Publicado: (2021)

Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
por: Reddy, Krishna P., et al.
Publicado: (2021)

The association between all-cause mortality and HIV acquisition risk groups in the United States, 2001–2014
por: Shebl, Fatma M., et al.
Publicado: (2023)

Projected Life Expectancy Gains From Improvements in HIV Care in Black and White Men Who Have Sex With Men
por: Rich, Katherine M., et al.
Publicado: (2023)

798. Life-years Gained among non-Hispanic Black and White Men who have Sex with Men in the United States with Improvements in the HIV Care Continuum A Simulation Modeling Study
por: Rich, Katherine M, et al.
Publicado: (2022)

Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa
por: Dugdale, Caitlin M., et al.
Publicado: (2019)

The Clinical Impact and Cost-Effectiveness of Clinic-Based Cognitive Behavioral Therapy for People With HIV, Depression, and Virologic Failure in South Africa
por: Gandhi, Aditya R., et al.
Publicado: (2023)

Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness
por: Bassett, Ingrid V., et al.
Publicado: (2014)

Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

Cost-effectiveness of a Medical Care Coordination Program for People With HIV in Los Angeles County
por: Flash, Moses J E, et al.
Publicado: (2019)

Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal
por: Losina, Elena, et al.
Publicado: (2009)

Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections
por: Neilan, Anne M., et al.
Publicado: (2021)

Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis
por: McCann, Nicole C., et al.
Publicado: (2020)

Impact of pre-exposure prophylaxis uptake among gay, bisexual, and other men who have sex with men in urban centers in Brazil: a modeling study
por: Luz, Paula M., et al.
Publicado: (2023)

Health impact and cost-effectiveness of HIV testing, linkage, and early antiretroviral treatment in the Botswana Combination Prevention Project
por: Resch, Stephen C., et al.
Publicado: (2022)

The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis
por: Hyle, Emily P., et al.
Publicado: (2014)

Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings
por: Dugdale, Caitlin M., et al.
Publicado: (2023)

Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions
por: Ciaranello, Andrea L, et al.
Publicado: (2011)

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
por: Linas, Benjamin P., et al.
Publicado: (2016)

Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers
por: Chen, Wanyi, et al.
Publicado: (2023)

Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population
por: Reddy, Krishna P, et al.
Publicado: (2020)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

Clinical Impact and Cost-Effectiveness of Expanded Voluntary HIV Testing in India
por: Venkatesh, Kartik K., et al.
Publicado: (2013)

Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India
por: Freedberg, Kenneth A., et al.
Publicado: (2018)

Cost-Effectiveness of Genotype Testing for Primary Resistance in Brazil
por: Luz, Paula M., et al.
Publicado: (2015)

Cost-effectiveness of Routine Provider-Initiated Testing and Counseling for Children With Undiagnosed HIV in South Africa
por: Stanic, Tijana, et al.
Publicado: (2021)

Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus
por: Reddy, Krishna P, et al.
Publicado: (2020)

965. Projecting the Potential Clinical and Economic Impact of HIV Prevention Resource Reallocation in Tennessee
por: Borre, Ethan D, et al.
Publicado: (2023)

Massachusetts
por: Rogers, Howard P.
Publicado: (1896)

Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India
por: Uhler, Lauren M., et al.
Publicado: (2010)

The Cost-Effectiveness of Tuberculosis Preventive Therapy for HIV-Infected Individuals in Southern India: A Trial-Based Analysis
por: Pho, Mai T., et al.
Publicado: (2012)

Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub‐Saharan African settings: a cost‐effectiveness analysis
por: Dunning, Lorna, et al.
Publicado: (2021)

Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe
por: Hyle, Emily P, et al.
Publicado: (2022)

Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness
por: Yazdanpanah, Yazdan, et al.
Publicado: (2010)

Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis
por: Resch, Stephen C, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_6eb3l0s4m6gc1kp9vquri7jgff